Pharmaceutical Market Access and Drug Safety Act of 2011
Latest action · Feb 10, 2011 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 10, 2011
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Market Access and Drug Safety Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by a registered importeror an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services (HHS) to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.
Cosponsors 21
Members who signed on, in the order they did. Signatures ran from Feb 10, 2011 to Jul 14, 2011, with 18 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MN | Amy Klobuchar | Original | Feb 10, 2011 |
| I-VT | Bernard Sanders | Original | Feb 10, 2011 |
| D-FL | Bill Nelson | Original | Feb 10, 2011 |
| D-MI | Carl Levin | Original | Feb 10, 2011 |
| R-IA | Chuck Grassley | Original | Feb 10, 2011 |
| D-MO | Claire McCaskill | Original | Feb 10, 2011 |
| R-LA | David Vitter | Original | Feb 10, 2011 |
| D-MI | Debbie Stabenow | Original | Feb 10, 2011 |
| D-WI | Herb Kohl | Original | Feb 10, 2011 |
| D-NH | Jeanne Shaheen | Original | Feb 10, 2011 |
| D-NM | Jeff Bingaman | Original | Feb 10, 2011 |
| D-MA | John F. Kerry | Original | Feb 10, 2011 |
| R-AZ | John McCain | Original | Feb 10, 2011 |
| D-AK | Mark Begich | Original | Feb 10, 2011 |
| D-VT | Patrick J. Leahy | Original | Feb 10, 2011 |
Actions 3
Everything that happened, newest first.
- Feb 10, 2011Introduced in Senate
- Feb 10, 2011Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Feb 10, 2011Sponsor introductory remarks on measure. (CR S644-645)
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Administrative law and regulatory procedures
- Administrative remedies
- Asia
- Australia
- Business records
- Canada
- Civil actions and liability
- Consumer affairs
- Consumer credit
- Contracts and agency
- Department of Health and Human Services
- Europe
- European Union
- Evidence and witnesses
- Federal preemption
- Federal Trade Commission (FTC)
- Food and Drug Administration (FDA)
- Fraud offenses and financial crimes
- Government studies and investigations
- Health
- Health information and medical records
- Intellectual property
- Intergovernmental relations
- Internet and video services
- Internet, web applications, social media
- Japan
- Manufacturing
- Marketing and advertising
- Medical education
- Medical tests and diagnostic methods
- New Zealand
- Oceania
- Prescription drugs
- Product safety and quality
- Retail and wholesale trades
- Switzerland
- Trade restrictions
- User charges and fees
Text 1
Each version as it was printed, newest first.
- Feb 10, 2011Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.